CoCensys Names New Leader in a Series of Company Moves

Daniel L. Korpolinski has been appointed president and chief executive of CoCensys Inc., a privately held biopharmaceutical company in Irvine. He succeeds Robert G. Neil, who will serve as chairman. Korpolinski was formerly president of Adria Laboratories, North America. Before that, he spent 24 years at Upjohn Co. In addition, CoCensys announced that Kelvin W. Gee has been appointed chief scientific officer and that Donald W. Ashbrook has been appointed vice president of scientific affairs.